Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

EKSO | Ekso Bionics Holdings, Inc.

Index- P/E- EPS (ttm)-1.21 Insider Own13.30% Shs Outstand13.64M Perf Week-5.01%
Market Cap10.55M Forward P/E- EPS next Y-0.87 Insider Trans-4.66% Shs Float11.38M Perf Month-26.68%
Income-16.10M PEG- EPS next Q-0.31 Inst Own16.50% Short Float / Ratio0.32% / 0.69 Perf Quarter-48.51%
Sales15.70M P/S0.67 EPS this Y-31.40% Inst Trans2.85% Short Interest0.04M Perf Half Y-53.06%
Book/sh1.31 P/B0.53 EPS next Y32.60% ROA-42.60% Target Price9.00 Perf Year-64.06%
Cash/sh0.87 P/C0.79 EPS next 5Y- ROE-69.10% 52W Range0.62 - 1.90 Perf YTD-42.02%
Dividend- P/FCF- EPS past 5Y37.60% ROI-49.40% 52W High-63.78% Beta1.78
Dividend %- Quick Ratio1.90 Sales past 5Y11.90% Gross Margin48.50% 52W Low11.29% ATR0.09
Employees60 Current Ratio2.40 Sales Q/Q34.30% Oper. Margin- RSI (14)32.36 Volatility13.39% 11.77%
OptionableYes Debt/Eq0.35 EPS Q/Q-34.20% Profit Margin- Rel Volume1.29 Prev Close0.69
ShortableYes LT Debt/Eq0.19 EarningsJul 27 AMC Payout- Avg Volume52.68K Price0.69
Recom2.00 SMA20-17.36% SMA50-32.80% SMA200-49.84% Volume68,063 Change0.57%
Date Action Analyst Rating Change Price Target Change
Oct-14-16Initiated SunTrust Buy
Sep-11-23 08:00AM
Jul-28-23 06:45AM
Jul-27-23 05:25PM
08:00AM Loading…
Jul-20-23 08:00AM
Apr-27-23 05:02PM
Apr-20-23 08:00AM
Apr-19-23 03:58PM
Apr-17-23 04:05PM
Mar-30-23 08:01AM
Mar-28-23 04:46PM
Mar-20-23 08:00AM
08:00AM Loading…
Feb-23-23 08:00AM
Dec-05-22 08:37AM
Nov-09-22 05:31AM
Nov-03-22 06:05PM
Oct-27-22 08:00AM
Sep-11-22 08:10AM
Sep-06-22 04:05PM
Jul-28-22 05:35PM
Jul-21-22 08:00AM
Jun-13-22 08:00AM
May-26-22 07:00AM
May-17-22 04:05PM
May-13-22 09:55AM
05:35PM Loading…
Apr-28-22 05:35PM
Apr-21-22 10:25AM
Feb-24-22 06:00PM
Feb-17-22 08:00AM
Feb-05-22 08:25AM
Jan-21-22 04:01PM
Jan-10-22 09:00AM
Jan-04-22 08:30AM
Dec-28-21 04:05PM
Dec-16-21 04:15PM
Nov-02-21 06:25PM
Oct-26-21 08:00AM
Sep-07-21 04:04PM
Aug-09-21 02:48AM
Jul-29-21 06:15PM
Jul-22-21 03:03PM
May-27-21 09:04AM
May-13-21 06:18AM
May-11-21 04:38PM
May-05-21 09:15AM
Apr-29-21 04:05PM
Apr-22-21 12:33PM
Apr-12-21 07:57AM
Mar-09-21 08:00AM
Mar-03-21 08:00AM
Mar-02-21 08:00AM
Feb-25-21 05:15PM
Feb-24-21 10:21AM
Feb-18-21 08:00AM
Feb-11-21 04:35PM
Feb-10-21 01:41AM
Feb-08-21 11:30PM
Jan-22-21 04:23PM
Jan-13-21 04:05PM
Jan-05-21 08:00AM
Dec-30-20 08:00AM
Nov-29-20 02:56AM
Nov-27-20 01:08PM
Nov-10-20 08:00AM
Oct-29-20 04:05PM
Oct-22-20 08:00AM
Sep-09-20 08:00AM
Aug-31-20 10:04AM
Aug-20-20 08:30AM
Jul-30-20 07:10PM
Jul-27-20 11:22AM
Jul-23-20 08:00AM
Jul-09-20 08:00AM
Jun-26-20 02:28PM
Jun-25-20 12:27PM
Jun-15-20 12:00PM
Jun-10-20 01:30PM
Jun-08-20 08:00AM
Jun-03-20 08:00AM
Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Europe, the Middle east, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. The company also provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; Ekso Indego Therap, an adjustable and lower-limb powered exoskeleton; and Ekso Indego Personal, a powered lower limb orthosis. It has a license agreement with Lockheed Martin Corporation. The company was incorporated in 2005 and is headquartered in San Rafael, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Davis Scott G.President & COOAug 17Sale1.0037,44637,281331,372Aug 18 09:44 PM
Wong JeromeChief Financial OfficerAug 17Sale1.0012,78412,728266,953Aug 18 09:40 PM
SHERMAN STEVENExecutive ChairMay 24Sale1.4445,66065,874364,913May 26 06:45 PM
Jones Jason CChief Operating OfficerMay 08Sale1.573,4355,401138,554May 17 07:42 PM
SHERMAN STEVENExecutive ChairDec 04Option Exercise0.0031,1980739,240Dec 07 09:09 PM
SHERMAN STEVENExecutive ChairDec 04Sale1.2810,57613,492728,664Dec 07 09:09 PM
SHERMAN STEVENCEO & ChairmanNov 21Option Exercise0.0015,5990713,829Nov 23 03:17 PM
SHERMAN STEVENCEO & ChairmanNov 21Sale1.265,7877,312708,042Nov 23 03:17 PM
Jones Jason CSenior VP Product DevelopmentNov 16Sale1.287821,003124,982Nov 17 05:49 PM
Wong JeromeChief Financial OfficerNov 16Sale1.28723927101,469Nov 17 05:47 PM
SHERMAN STEVENCEO & ChairmanOct 24Sale1.295,9217,619698,230Oct 26 06:31 PM
SHERMAN STEVENCEO & ChairmanOct 21Option Exercise0.0015,6000704,151Oct 26 06:31 PM